Viewing StudyNCT00211133



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00211133
Status: COMPLETED
Last Update Posted: 2010-11-30
First Post: 2005-09-13

Brief Title: A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Quality of Life
Anemia
Breast Neoplasms
Keywords:
Name View
erythropoietin View
Anemia View
Breast Cancer View
Breast Tumor View
Quality of Life View
Women View
Female View
Chemotherapy View
Hemoglobin View
Survival View
Epoetin View
Epoetin alfa View